{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T12:35:55Z","timestamp":1742646955639,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09941-4","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T21:01:34Z","timestamp":1728075694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the role of EGFR exon 19 747\u2013750 deletion mutation and plasma amino acid profile in the development of lung cancer"],"prefix":"10.1007","volume":"51","author":[{"given":"Tahia H.","family":"Saleem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein","family":"Elkhayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Farouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fify Alfy","family":"Gabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esraa A.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7567-7022","authenticated-orcid":false,"given":"Amira A.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"9941_CR1","first-page":"45","volume":"25","author":"KC Thandra","year":"2021","unstructured":"Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A (2021) Epidemiology of lung cancer. Contem Oncol (Poznan, Poland) 25:45\u201352","journal-title":"Contem Oncol (Poznan, Poland)"},{"key":"9941_CR2","doi-asserted-by":"publisher","first-page":"104752","DOI":"10.1016\/j.compbiomed.2021.104752","volume":"136","author":"Z Khodabakhshi","year":"2021","unstructured":"Khodabakhshi Z, Mostafaei S, Arabi H, Oveisi M, Shiri I, Zaidi H (2021) Non-small cell lung carcinoma histopathological subtype phenotyping using high-dimensional multinomial multiclass CT radiomics signature. Comput Biol Med 136:104752","journal-title":"Comput Biol Med"},{"key":"9941_CR3","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/cac2.12359","volume":"42","author":"P Chen","year":"2022","unstructured":"Chen P, Liu Y, Wen Y, Zhou C (2022) Non-small cell lung cancer in China. Cancer Commun (Lond, Eng) 42:937\u2013970","journal-title":"Cancer Commun (Lond, Eng)"},{"key":"9941_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-022-01505-z","volume":"21","author":"W Li","year":"2022","unstructured":"Li W, Liu JB, Hou LK, Yu F, Zhang J, Wu W, Tang XM, Sun F, Lu HM, Deng J, Bai J, Li J, Wu CY, Lin QL, Lv ZW, Wang GR, Jiang GX, Ma YS, Fu D (2022) Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring. Mol Cancer 21:25","journal-title":"Mol Cancer"},{"key":"9941_CR5","doi-asserted-by":"publisher","first-page":"25055","DOI":"10.3390\/ijms24032505","volume":"24","author":"GMS Casagrande","year":"2023","unstructured":"Casagrande GMS, Silva MO, Reis RM, Leal LF (2023) Liquid biopsy for lung cancer: up-to-date and perspectives for screening programs. Int J Mol Sci 24:25055","journal-title":"Int J Mol Sci"},{"key":"9941_CR6","doi-asserted-by":"publisher","first-page":"105763","DOI":"10.1016\/j.jbc.2024.105763","volume":"300","author":"JL Macdonald-Obermann","year":"2024","unstructured":"Macdonald-Obermann JL, Pike LJ (2024) Extracellular domain mutations of the EGF receptor differentially modulate high-affinity and low-affinity responses to EGF receptor ligands. J Biol Chem 300:105763","journal-title":"J Biol Chem"},{"key":"9941_CR7","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/ijms22020593","volume":"22","author":"A Rybarczyk-Kasiuchnicz","year":"2021","unstructured":"Rybarczyk-Kasiuchnicz A, Ramlau R, Stencel K (2021) Treatment of brain metastases of non-small cell lung carcinoma. Int J Mol Sci 22:593","journal-title":"Int J Mol Sci"},{"key":"9941_CR8","doi-asserted-by":"publisher","first-page":"100907","DOI":"10.1016\/j.tranon.2020.100907","volume":"14","author":"Y Xie","year":"2021","unstructured":"Xie Y, Meng WY, Li RZ, Wang YW, Qian X, Chan C, Yu ZF, Fan XX, Pan HD, Xie C, Wu QB, Yan PY, Liu L, Tang YJ, Yao XJ, Wang MF, Leung EL (2021) Early lung cancer diagnostic biomarker discovery by machine learning methods. Translational oncology 14:100907","journal-title":"Translational oncology"},{"key":"9941_CR9","doi-asserted-by":"crossref","unstructured":"Saha, S., Ghosh, M., (2024) The role of one-carbon amino acids in tumor-immune metabolism: From oncogenesis to therapy, Elsevier, pp. 51\u201368.","DOI":"10.1016\/B978-0-443-13209-4.00007-6"},{"key":"9941_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189151","author":"VG Varzieva","year":"2024","unstructured":"Varzieva VG, Mesonzhnik NV, Ilgisonis IS, Belenkov YN, Kozhevnikova MV, Appolonova SA (2024) Metabolomic biomarkers of multiple myeloma: a systematic review. Biochimica et Biophysica Acta (BBA)-Rev Cancer. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189151","journal-title":"Biochimica et Biophysica Acta (BBA)-Rev Cancer"},{"key":"9941_CR11","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1111\/jvim.15512","volume":"33","author":"R Leela-Arporn","year":"2019","unstructured":"Leela-Arporn R, Ohta H, Tamura M, Nagata N, Sasaoka K, Dermlim A, Nisa K, Osuga T, Morishita K, Sasaki N, Takiguchi M (2019) Plasma-free amino acid profiles in dogs with hepatocellular carcinoma. J Vet Intern Med 33:1653\u20131659","journal-title":"J Vet Intern Med"},{"key":"9941_CR12","doi-asserted-by":"publisher","first-page":"603837","DOI":"10.3389\/fcell.2020.603837","volume":"8","author":"Z Wei","year":"2020","unstructured":"Wei Z, Liu X, Cheng C, Yu W, Yi P (2020) Metabolism of amino acids in cancer. Frontiers in cell and developmental biology 8:603837","journal-title":"Frontiers in cell and developmental biology"},{"key":"9941_CR13","doi-asserted-by":"publisher","first-page":"e13272","DOI":"10.7717\/peerj.13272","volume":"10","author":"K Liu","year":"2022","unstructured":"Liu K, Li J, Long T, Wang Y, Yin T, Long J, Shen Y, Cheng L (2022) Changes in serum amino acid levels in non-small cell lung cancer: a case-control study in Chinese population. PeerJ 10:e13272","journal-title":"PeerJ"},{"key":"9941_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.17546\/msd.569279","volume":"6","author":"DY Ertural","year":"2019","unstructured":"Ertural DY, Nayir E, Arpaci RB, Eker ED, Nazan E, Yildirim DD, Akba\u015f E (2019) The effects of EGFR exon 19 747\u2013750 deletion on the risk of developing lung cancer. Med Sci Dis 6:109\u2013113","journal-title":"Med Sci Dis"},{"key":"9941_CR15","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/cancers15041321","volume":"15","author":"J Bidzi\u0144ska","year":"2023","unstructured":"Bidzi\u0144ska J, Szurowska E (2023) See lung cancer with an AI. Cancers 15:1321","journal-title":"Cancers"},{"key":"9941_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-023-01740-y","volume":"22","author":"A Lahiri","year":"2023","unstructured":"Lahiri A, Maji A, Potdar PD, Singh N, Parikh P, Bisht B, Mukherjee A, Paul MK (2023) Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer 22:1\u201337","journal-title":"Mol Cancer"},{"key":"9941_CR17","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.3390\/cancers15133414","volume":"15","author":"R Chinnappan","year":"2023","unstructured":"Chinnappan R, Mir TA, Alsalameh S, Makhzoum T, Alzhrani A, Alnajjar K, Adeeb S, Al Eman N, Ahmed Z, Shakir I (2023) Emerging biosensing methods to monitor lung cancer biomarkers in biological samples: a comprehensive review. Cancers 15:3414","journal-title":"Cancers"},{"key":"9941_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s10555-021-09962-6","volume":"40","author":"A Jouida","year":"2021","unstructured":"Jouida A, McCarthy C, Fabre A, Keane MP (2021) Exosomes: a new perspective in EGFR-mutated lung cancer. Cancer Metastasis Rev 40:589\u2013601","journal-title":"Cancer Metastasis Rev"},{"key":"9941_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102664","author":"F Ciardiello","year":"2023","unstructured":"Ciardiello F, Hirsch FR, Pirker R, Felip E, Valencia C, Smit EF (2023) The role of anti-EGFR therapies in EGFR-TKI-resistant advanced non-small cell lung cancer. Cancer Treat Rev. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102664","journal-title":"Cancer Treat Rev"},{"key":"9941_CR20","unstructured":"Basolo, A., Matrone, A., Elisei, R., Santini, F., Elsevier, pp. 197\u2013202."},{"key":"9941_CR21","doi-asserted-by":"publisher","first-page":"6382","DOI":"10.1158\/1078-0432.CCR-19-0780","volume":"25","author":"A Truini","year":"2019","unstructured":"Truini A, Starrett JH, Stewart T, Ashtekar K, Walther Z, Wurtz A, Lu D, Park JH, DeVeaux M, Song X, Gettinger S, Zelterman D, Lemmon MA, Goldberg SB, Politi K (2019) The EGFR exon 19 mutant L747\u2013A750>P exhibits distinct sensitivity to tyrosine kinase inhibitors in lung adenocarcinoma. Clinl Cancer Res: Off J Am Assoc Cancer Res 25:6382\u20136391","journal-title":"Clinl Cancer Res: Off J Am Assoc Cancer Res"},{"key":"9941_CR22","doi-asserted-by":"publisher","first-page":"100791","DOI":"10.1016\/j.tranon.2020.100791","volume":"13","author":"CW Xu","year":"2020","unstructured":"Xu CW, Lei L, Wang WX, Lin L, Zhu YC, Wang H, Miao LY, Wang LP, Zhuang W, Fang MY, Lv TF, Song Y (2020) Molecular characteristics and clinical outcomes of EGFR exon 19 C-helix deletion in non-small cell lung cancer and response to EGFR TKIs. Transl Oncol 13:100791","journal-title":"Transl Oncol"},{"key":"9941_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab177","author":"WS van de Geer","year":"2022","unstructured":"van de Geer WS, Hoogstrate Y, Draaisma K, Robe PA, Bins S, Mathijssen RHJ, French P, van de Werken HJG, de Vos FYF (2022) Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomas. Neuro Oncol Adv. https:\/\/doi.org\/10.1093\/noajnl\/vdab177","journal-title":"Neuro Oncol Adv"},{"key":"9941_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/cancers11030366","volume":"11","author":"T Le","year":"2019","unstructured":"Le T, Gerber DE (2019) Newer-generation EGFR inhibitors in lung cancer: how are they best used? Cancers 11:366","journal-title":"Cancers"},{"key":"9941_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s13139-020-00646-7","volume":"54","author":"W Whi","year":"2020","unstructured":"Whi W, Ha S, Bae S, Choi H, Paeng JC, Cheon GJ, Kang KW, Lee DS (2020) Relationship of EGFR mutation to glucose metabolic activity and asphericity of metabolic tumor volume in lung adenocarcinoma. Nucl Med Mol Imaging 54:175\u2013182","journal-title":"Nucl Med Mol Imaging"},{"key":"9941_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cllc.2021.09.004","volume":"23","author":"JA Hellyer","year":"2022","unstructured":"Hellyer JA, White MN, Gardner RM, Cunanan K, Padda SK, Das M, Ramchandran K, Neal JW, Wakelee HA (2022) Impact of tumor suppressor gene co-mutations on differential response to EGFR TKI therapy in EGFR L858R and Exon 19 deletion lung cancer. Clin Lung Cancer 23:264\u2013272","journal-title":"Clin Lung Cancer"},{"key":"9941_CR27","doi-asserted-by":"publisher","first-page":"680804","DOI":"10.3389\/fonc.2021.680804","volume":"11","author":"R Jin","year":"2021","unstructured":"Jin R, Peng L, Shou J, Wang J, Jin Y, Liang F, Zhao J, Wu M, Li Q, Zhang B (2021) EGFR-mutated squamous cell lung cancer and its association with outcomes. Front Oncol 11:680804","journal-title":"Front Oncol"},{"key":"9941_CR28","doi-asserted-by":"publisher","first-page":"e0228925","DOI":"10.1371\/journal.pone.0228925","volume":"15","author":"H-Y Yoon","year":"2020","unstructured":"Yoon H-Y, Ryu J-S, Sim YS, Kim D, Lee SY, Choi J, Park S, Ryu YJ, Lee JH, Chang JH (2020) Clinical significance of EGFR mutation types in lung adenocarcinoma: a multi-centre Korean study. PLoS ONE 15:e0228925","journal-title":"PLoS ONE"},{"key":"9941_CR29","doi-asserted-by":"publisher","first-page":"e2206588119","DOI":"10.1073\/pnas.2206588119","volume":"119","author":"BP Brown","year":"2022","unstructured":"Brown BP, Zhang Y-K, Kim S, Finneran P, Yan Y, Du Z, Kim J, Hartzler AL, LeNoue-Newton ML, Smith AW (2022) Allele-specific activation, enzyme kinetics, and inhibitor sensitivities of EGFR exon 19 deletion mutations in lung cancer. Proc Natl Acad Sci 119:e2206588119","journal-title":"Proc Natl Acad Sci"},{"key":"9941_CR30","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.21037\/tcr-22-865","volume":"11","author":"C Zhang","year":"2022","unstructured":"Zhang C, Wang Y, Cao Y, Shi L, Wang R, Sheng N, Wang Q, Zhu Z (2022) Study on plasma amino acids and piperonamide as potential diagnostic biomarkers of non-small cell lung cancer. Trans Cancer Res 11:1269\u20131284","journal-title":"Trans Cancer Res"},{"key":"9941_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/cells11030413","volume":"11","author":"K Eltayeb","year":"2022","unstructured":"Eltayeb K, La Monica S, Tiseo M, Alfieri R, Fumarola C (2022) Reprogramming of lipid metabolism in lung cancer: an overview with focus on EGFR-mutated non-small cell lung cancer. Cells 11:413","journal-title":"Cells"},{"key":"9941_CR32","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/metabo13080950","volume":"13","author":"LV Belskaya","year":"2023","unstructured":"Belskaya LV, Sarf EA, Loginova AI (2023) Diagnostic value of salivary amino acid levels in cancer. Metabolites 13:950","journal-title":"Metabolites"},{"key":"9941_CR33","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/metabo11090630","volume":"11","author":"D Madama","year":"2021","unstructured":"Madama D, Martins R, Pires AS, Botelho MF, Alves MG, Abrantes AM, Cordeiro CR (2021) Metabolomic profiling in lung cancer: a systematic review. Metabolites 11:630","journal-title":"Metabolites"},{"key":"9941_CR34","first-page":"2145","volume":"10","author":"H Namikawa-Kanai","year":"2020","unstructured":"Namikawa-Kanai H, Miyazaki T, Matsubara T, Shigefuku S, Ono S, Nakajima E, Morishita Y, Honda A, Furukawa K, Ikeda N (2020) Comparison of the amino acid profile between the nontumor and tumor regions in patients with lung cancer. Am J Cancer Res 10:2145","journal-title":"Am J Cancer Res"},{"key":"9941_CR35","doi-asserted-by":"publisher","first-page":"7304","DOI":"10.1038\/s41598-023-34575-0","volume":"13","author":"KS Kim","year":"2023","unstructured":"Kim KS, Moon SW, Moon MH, Hyun KY, Kim SJ, Kim YK, Kim KY, Jekarl DW, Oh EJ, Kim Y (2023) Metabolic profiles of lung adenocarcinoma via peripheral blood and diagnostic model construction. Sci Rep 13:7304","journal-title":"Sci Rep"},{"key":"9941_CR36","first-page":"188","volume":"18","author":"J Ni","year":"2019","unstructured":"Ni J, Xu L, Li W, Zheng C, Wu L (2019) Targeted metabolomics for serum amino acids and acylcarnitines in patients with lung cancer. Exp Ther Med 18:188\u2013198","journal-title":"Exp Ther Med"},{"key":"9941_CR37","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.3390\/cancers13133314","volume":"13","author":"T Kowalczyk","year":"2021","unstructured":"Kowalczyk T, Kisluk J, Pietrowska K, Godzien J, Kozlowski M, Resze\u0107 J, Sierko E, Naumnik W, Mr\u00f3z R, Moniuszko M, Kretowski A, Niklinski J, Ciborowski M (2021) The ability of metabolomics to discriminate non-small-cell lung cancer subtypes depends on the stage of the disease and the type of material studied. Cancers 13:3314","journal-title":"Cancers"},{"key":"9941_CR38","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/molecules27030819","volume":"27","author":"T Amelia","year":"2022","unstructured":"Amelia T, Kartasasmita RE, Ohwada T, Tjahjono DH (2022) structural insight and development of EGFR tyrosine kinase inhibitors. Molecules 27:819","journal-title":"Molecules"},{"key":"9941_CR39","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.3390\/cancers12082266","volume":"12","author":"B Colella","year":"2020","unstructured":"Colella B, Colardo M, Iannone G, Contadini C, Saiz-Ladera C, Fuoco C, Baril\u00e0 D, Velasco G, Segatto M, Di Bartolomeo S (2020) mTOR inhibition leads to src-mediated EGFR internalisation and degradation in glioma cells. Cancers 12:2266","journal-title":"Cancers"},{"key":"9941_CR40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1152\/physiolgenomics.00061.2023","volume":"55","author":"Y Tan","year":"2023","unstructured":"Tan Y, Chrysopoulou M, Rinschen MM (2023) Integrative physiology of lysine metabolites. Physiol Genomics 55:579\u2013586","journal-title":"Physiol Genomics"},{"key":"9941_CR41","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/nu12030848","volume":"12","author":"M Hole\u010dek","year":"2020","unstructured":"Hole\u010dek M (2020) Histidine in health and disease: metabolism, physiological importance, and use as a supplement. Nutrients 12:848","journal-title":"Nutrients"},{"key":"9941_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/metabo11020083","volume":"11","author":"L Lauinger","year":"2021","unstructured":"Lauinger L, Kaiser P (2021) Sensing and signaling of methionine metabolism. Metabolites 11:83","journal-title":"Metabolites"},{"key":"9941_CR43","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.3390\/nu13082592","volume":"13","author":"Q Tang","year":"2021","unstructured":"Tang Q, Tan P, Ma N, Ma X (2021) Physiological functions of threonine in animals: beyond nutrition metabolism. Nutrients 13:2592","journal-title":"Nutrients"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09941-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09941-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09941-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:30:08Z","timestamp":1738729808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09941-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9941"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09941-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"assertion":[{"value":"3 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Assiut University Faculty of Medicine\u2019s ethical committee gave its approval to this research protocol (IRB number17300795).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"1039"}}